Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration ...
MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback